Interactive Inpatient Asthma Education: A Randomized Controlled Trial
- PMID: 35190827
- DOI: 10.1542/hpeds.2021-006259
Interactive Inpatient Asthma Education: A Randomized Controlled Trial
Abstract
Background and objectives: Inpatient asthma education interventions provide benefit compared with usual care, but evaluation of the most effective educational model is needed. We compared the impact of interactive versus didactic inpatient pediatric asthma education on subsequent emergency department (ED) visits and hospitalizations.
Methods: Children (aged 2‒16) with asthma admitted to a tertiary care children's hospital with an asthma exacerbation between October 2016 and June 2017 were randomly assigned to interactive or didactic (control) asthma education. The primary outcome was asthma ED visits at 6 and 12 months; secondary outcomes included hospitalizations (6 and 12 months), inhaler technique, asthma knowledge, symptoms, quality of life, and parental management skills at baseline, discharge, and/or 12 months.
Results: One hundred forty participants (69 interactive, 71 control) completed the study. There were no differences in ED visits at 6 or 12 months. Compared to controls, the interactive group had fewer hospitalizations (10.1% vs 22.5%; P = .04) at 6 months. Inhaler technique in the interactive group improved at discharge (mean change 4.07 [95% confidence interval (CI): 3.21-4.94]) and remained increased at 12 months (P = .03). Patient-reported asthma symptoms and quality of life were similar in both groups at baseline (19.9 vs 20.62, best possible score 8) and significantly improved in the interactive group at 12 months (least square mean change, 3.52 vs -1.75; P < .01).
Conclusions: There were no differences in ED visits; however, the interactive education reduced asthma hospitalizations over a 6-month period. These findings demonstrate that educational delivery methods can play a role in improving clinical outcomes for asthma.
Copyright © 2022 by the American Academy of Pediatrics.
Conflict of interest statement
CONFLICT OF INTEREST DISCLOSURE: Dr Press reports consulting for Vizient, Roundglass, and Humana. Dr Gupta reports receiving research support from the National Institutes of Health (R21 ID AI135705, R01 ID AI130348, U01 ID AI138907), Food Allergy Research Education, ρ Inc, Melchiorre Family Foundation, Sunshine Charitable Foundation, Walder Foundation, UnitedHealth Group, Thermo Fisher Scientific, Genentech, and the National Confectioners Association; and also serves as a medical consultant/advisor for Aimmune Therapeutics, Before Brands, AllerGenis LLC, Kaléo Inc, Novartis, Genentech, DBV Technologies, and Food Allergy Research and Education. The other authors have indicated they have no potential conflicts of interest to disclose.
Comment in
-
Pediatric Hospital Medicine Needs More Randomized Controlled Trials.Hosp Pediatr. 2022 Mar 1;12(3):e116-e118. doi: 10.1542/hpeds.2021-006429. Epub 2022 Feb 22. Hosp Pediatr. 2022. PMID: 35190804 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
